Peter Blume Jensen Acrivon Therapeutics, Inc. (ACRV) insider trading activity

ACRV Quotes by TradingView

Peter Blume-Jensen Transaction History

Date Transaction Value Shares Traded Form
Nov 14 2024
SELL
Payment of exercise price or tax liability
$3,880 $7.92 p/Share
490
Nov 14 2022
BUY
Grant, award, or other acquisition
-
26,707
PB

Peter Blume Jensen

President and CEO
Watertown, MA

Track Institutional and Insider Activities on ACRV

Follow Acrivon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRV shares.

Notify only if

Insider Trading

Get notified when an Acrivon Therapeutics, Inc. insider buys or sells ACRV shares.

Notify only if

News

Receive news related to Acrivon Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACRV